title: [Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha].
authors: A
authors: A
authors: Sabbah
mesh_terms: D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D008658:Inactivation, Metabolic; D015994:Incidence; D007223:Infant; D015570:Josamycin / Q000494:pharmacology; D007654:Ketoconazole / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D012189:Retrospective Studies; D012306:Risk; D016593:Terfenadine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D004917:Erythromycin; D016593:Terfenadine; D003577:Cytochrome P-450 Enzyme System; D015570:Josamycin; D007654:Ketoconazole
vernacular_title: Teldane, mise au point... Interview du Dr. Alfred Sabbah, chef du laboratoire d'immuno-allergologie du C.H.U. d'Angers.